Medicare Enrolled

Dr. Johanna Vivienne Leyco-Policarpio, M.D.

Endocrinology · Katy, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
21308 PROVINCIAL BLVD, Katy, TX 77450
2812068201
In practice since 2009 (16 years)
NPI: 1659508265 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Leyco-Policarpio from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Leyco-Policarpio? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Leyco-Policarpio

Dr. Johanna Vivienne Leyco-Policarpio is an endocrinology in Katy, TX, with 16 years in practice. Based on federal Medicare data, Dr. Leyco-Policarpio performed 293 Medicare services across 147 unique beneficiaries.

Between the years covered by Open Payments, Dr. Leyco-Policarpio received a total of $18,477 from 60 pharmaceutical and/or device companies across 996 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Leyco-Policarpio is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ 293 Medicare services$ $18,477 industry payments

Medicare Practice Summary

Medicare Utilization ↗
293
Medicare services
Bottom 26% in TX for endocrinology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
147
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~18 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)228$97$251
Office visit, established patient, complex (40-54 min)29$138$353
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report24$27$69
New patient office visit (45-59 min)12$122$326
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$18,477
Total received (2018-2024)
Avg $2,640/year across 7 years
Top 23% in TX for endocrinology
60
Companies
996
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,477 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,068
2023
$1,485
2022
$2,434
2021
$2,892
2020
$3,233
2019
$3,464
2018
$3,902

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$3,625
Novo Nordisk Inc
$1,692
Lilly USA, LLC
$1,278
SANOFI-AVENTIS U.S. LLC
$1,039
Boehringer Ingelheim Pharmaceuticals, Inc.
$864
Valeritas, Inc.
$805
Amgen Inc.
$785
Dexcom, Inc.
$708
MannKind Corporation
$706
Abbott Laboratories
$611
Mannkind Corporation
$602
Zealand Pharma US, Inc.
$445
Merck Sharp & Dohme Corporation
$402
Corcept Therapeutics
$367
IBSA Pharma Inc.
$335
ABBVIE INC.
$321
Esperion Therapeutics, Inc.
$290
DEXCOM, INC.
$279
PFIZER INC.
$267
Radius Health, Inc.
$252
Janssen Pharmaceuticals, Inc
$239
Tandem Diabetes Care, Inc.
$218
Intuity Medical Inc
$207
Insulet Corporation
$181
AbbVie Inc.
$157
Amarin Pharma Inc.
$152
Embecta Corp.
$133
Endo Pharmaceuticals Inc.
$124
AbbVie, Inc.
$121
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$108
Senseonics, Incorporated
$104
Shire North American Group Inc
$98
Currax Pharmaceuticals LLC
$89
Alexion Pharmaceuticals, Inc.
$83
CeQur Corporation
$79
Nevro Corp.
$66
Regeneron Healthcare Solutions, Inc.
$66
Gemini Laboratories, LLC
$52
Becton, Dickinson and Company
$48
RECORDATI_RARE_DISEASES_INC.
$44
Companion Medical, Inc.
$44
Amneal Pharmaceuticals LLC
$37
LifeScan, Inc.
$31
VIVUS, Inc.
$26
Kowa Pharmaceuticals America, Inc.
$25
Nalpropion Pharmaceuticals LLC
$23
GRT US Holding, Inc.
$23
Xeris Pharmaceuticals, Inc.
$21
Medicure Pharma Inc.
$20
Merck Sharp & Dohme LLC
$19
Medtronic MiniMed, Inc.
$19
VIVUS LLC
$19
Althera Pharmaceuticals LLC
$18
Sun Pharmaceutical Industries Inc.
$18
Ascensia Diabetes Care US Inc.
$18
EISAI INC.
$17
Nalpropion Pharmaceuticals, Inc.
$16
Bayer HealthCare Pharmaceuticals Inc.
$16
Tolmar, Inc.
$13
TheracosBio, LLC
$10
Top 3 companies account for 35.7% of total payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · BD Nano · BD Nano 2nd Gen Pen Needle · BYDUREON · Belviq · Brenzavvy · CONTRAVE · CYCLOSET · CeQur Simplicity · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · Eversense · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · Guardian Connect · HUMULIN · HUMULIN R 500 · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LICART · Livalo · MOUNJARO · NASCOBAL · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · Norditropin · Omnia · Omnipod · OneTouch · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · Qsymia · Qutenza · RECORLEV · RIOMET ER · RYBELSUS · Repatha · Roszet · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLUJAN · STRENSIQ · SYNJARDY · SYNTHROID · Saxenda · Senza · Strensiq · Synthroid · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VRAYLAR · Vascepa · Victoza · Wegovy · XARELTO · Xultophy 100/3.6 · ZEGALOGUE · ZYPITAMAG · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $6,306 per 100 Medicare services performed
Looking for a endocrinology in Katy?
Compare endocrinologys in the Katy area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
125
Per 100K population
2.6
County median income
$73,104
Nearest hospital
OCEANS BEHAVIORAL HOSPITAL OF KATY
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Leyco-Policarpio is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Leyco-Policarpio experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Leyco-Policarpio performed 228 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Leyco-Policarpio receive payments from pharmaceutical companies?
Yes. Dr. Leyco-Policarpio received a total of $18,477 from 60 companies across 996 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Leyco-Policarpio's costs compare to other endocrinologys in Katy?
Dr. Leyco-Policarpio's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Leyco-Policarpio) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →